Answers are grounded in this paper and cite their sources.
Influenza is an infectious disease caused by RNA viruses. Influenza viruses are unique among respiratory viruses due to their antigenic variability, which allows them to "evade" human immune defenses and cause annual epidemics. This necessitates the yearly development of new influenza vaccines tailored to the circulating strains. It is precisely this phenomenon of antigenic variation that explains why influenza remains a major epidemic disease affecting humanity. Despite significant scientific and theoretical progress in the study of this infection, it continues to pose extremely serious challenges to public health. In this context, the recent human infections with the avian influenza virus, specifically strain A (H5N1) have heightened the risk of the emergence of an influenza virus with pandemic potential. This underscores the necessity for vaccination and a thorough understanding of the disease's clinical course and potential complications. Furthermore, it highlights the importance of rapid diagnosis and the timely administration of specific anti-influenza medications; these drugs are most therapeutically effective when administered within the first 48 hours of symptom onset. Influenza vaccination is primarily recommended for individuals at high risk of developing a severe or complicated form of the disease, as well as for their close contacts.
No takes yet. Share an insight, caveat, or question.
Kahtan A.A. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: